Published Paper Details:

Non-small cell lung cancer (NSCLC) remains the most common cause of cancer-related motility. Surgery, radiation, chemotherapy, treatments, and immunotherapy separate or in combination are commonly used to treat lung cancer. The heterogeneous nature of this disease hinders its diagnosis and treatment, requiring continuous advances in research aiming to understand its intricate nature. Furthermore,the development of novel immunotherapies based on the recently highlights the real possibility of definitively treating NSCLC different side effect, mechanism of drug and chemotherapy based regimens appear to have reached a therapeutic plateau. we review the research on using current chemotherapy drugs and natural compounds. we review the research on using current chemotherapy drugs and natural compounds (Wortmannin and Roscovitine, Cordyceps militaris, Resveratrol, OSU03013, Myricetin, Berberine, Antroquinonol) and the beneficial effects they have on various types of cancers including non-small cell lung cancer.